D.E. Shaw & Co
PARN

D.E. Shaw & Co’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History

D.E. Shaw & Co’s Portfolio PARN Stock Details PARN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-116,498
Closed -$482K – 4379
2014
Q4 		$482K Sell
116,498
-35,797
-24% -$163K ﹤0.01% 3350
2014
Q3 		$876K Buy
+152,295
New +$917K ﹤0.01% 2910

Other funds holding PARN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

D.E. Shaw & Co's PARN Position: Q1 2015 in Review

D.E. Shaw & Co sold out of Parnell Pharmaceuticals Holdings Ltd (PARN) in Q1 2015, closing a stake of 116,498 shares — an estimated $482K sold.

D.E. Shaw & Co first reported a position in PARN in Q3 2014 and held it in 2 quarters. The position peaked at $876K in Q3 2014. 16 funds tracked by Wall St. Rank hold PARN as of Q1 2015.

  • D.E. Shaw & Co reported no remaining Parnell Pharmaceuticals Holdings Ltd position as of Q1 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 116,498 Parnell Pharmaceuticals Holdings Ltd shares in Q1 2015, an estimated $482K.
  • D.E. Shaw & Co first reported a position in Parnell Pharmaceuticals Holdings Ltd in Q3 2014 and held it in 2 quarters.
  • D.E. Shaw & Co's Parnell Pharmaceuticals Holdings Ltd position peaked at $876K in Q3 2014.
  • 16 funds tracked by Wall St. Rank held Parnell Pharmaceuticals Holdings Ltd as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.